Basic Stats
Institutional Owners | 22 total, 22 long only, 0 short only, 0 long/short - change of -4.35% MRQ |
Average Portfolio Allocation | 0.0303 % - change of 198.69% MRQ |
Institutional Shares (Long) | 1,382,302 (ex 13D/G) - change of 0.05MM shares 4.03% MRQ |
Institutional Value (Long) | $ 3,275 USD ($1000) |
Institutional Ownership and Shareholders
Mural Oncology PLC (IE:IE000LK2BOB4) has 22 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,382,302 shares. Largest shareholders include VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, VEXMX - Vanguard Extended Market Index Fund Investor Shares, BRUSX - Ultra-Small Company Fund Class N, FSMAX - Fidelity Extended Market Index Fund, VHCOX - Vanguard Capital Opportunity Fund Investor Shares, LFSC - F/m Emerald Life Sciences Innovation ETF, VHCIX - Vanguard Health Care Index Fund Admiral Shares, POAGX - PRIMECAP Odyssey Aggressive Growth Fund, IWC - iShares Micro-Cap ETF, and DLHAX - Delaware Healthcare Fund Class A .
Mural Oncology PLC (IE000LK2BOB4) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.
13F and NPORT Filings
Detail on 13F filings are free. Detail on NP filings require a premium membership. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.